Smart, Reusable Catheter System for Longitudinal Urinary Monitoring at the Point of Care
Electronics RESHAPED USA 2026
10 June 2026
Mountain View, California
Computer History Museum:
1401 N. Shoreline Blvd.
Mountain View, CA 94043
INTRODUCTION AND OBJECTIVES: Driven by the needs of individuals with spinal cord injury (SCI) who depend on intermittent urinary catheterization, CathBuddy, Inc. has developed the Aurie System, a reusable urinary catheter platform that features an FDA approved cleaning and disinfection unit to ensure sterile reusability. Building on this foundation, we present a Smart Catheter system that integrates reusable pressure (P), temperature (T), and pH sensors, and a replaceable chemi-resistive or colorimetric Leukocyte Esterase (LE) sensor, for real-time urodynamic monitoring. Data is then transmitted via Near Field Communication (NFC) technology at the point of care to the Aurie module during the post-catheterization cleaning cycle. Longitudinal bladder pressure monitoring offers clinical-level insight into bladder dynamics, while monitoring urinary T, pH, and LE monitoring support early detection of catheter-associated urinary tract infections (CAUTIs). By combining multimodal sensing with wireless data transmission to clinicians, this Smart Catheter has the potential to enhance the quality of life for SCI patients by promoting independence, reducing long-term healthcare costs, and facilitating more personalized patient care strategies.
METHODS: Commercial P and T sensors were down-selected based on biocompatibility, low power, and compact packaging, then were integrated into a 3D-printed catheter tip made with biocompatible elastomers. Custom potentiometric pH sensors were developed with Pt/Ir and Ag wires, as the working (WE) and reference (RE) electrodes, respectively, forming an electrochemical cell. The WE surface was activated to create iridium oxide sites, and open circuit potentiometry (OCP) measured voltage shifts due to hydronium ion activity. The fabricated pH sensors were calibrated with standard pH buffers. Integrated P and T sensors were validated in a customized bladder model setting against reference instruments. In this work, a replaceable chemi-resistive LE sensor was in-house developed by treating printed carbon electrodes with LE-reactive chemicals and calibrated by measuring the resistance change of the carbon electrode in proportion to the concentration of LE present in standardized analyte solutions. Responses were correlated to standard urine test strip color changes. We are
currently focused on developing a colorimetric LE sensor to replace the chemi-resistive sensor due to its reduced complexity and relative ease of incorporation, and simplified patient handling requirements.
RESULTS: A customized testing setup successfully demonstrated integration and reliable data transmission from the pressure (P) and temperature (T) sensors. The potentiometric pH sensors exhibited near-Nernstian behavior across a physiologically relevant pH range of 4.5–8.0, confirming their suitability for urinary monitoring. Measurement robustness and reproducibility were validated, and sensor functionality was maintained after multiple cleaning and disinfecting cycles following Aurie’s standardized procedures. LE sensor incorporation work is on-going.
CONCLUSIONS: This work validates a multimodal Smart-Catheter system capable of measuring pressure, temperature, and pH with wireless data transfer, and is progressing to include quantitative LE sensing capability. The T, P, and pH sensors-maintained stability, reproducibility, and responsiveness after repeated sterilization, demonstrating feasibility for reusable, point-of-care urinary monitoring platforms.
SOURCES OF FUNDING:
Funding for this work was provided by: 1) NYSTAR, and 2) Department of Defense grant #SC210249 awarded and administered by the U.S. Army Medical Research Acquisition Activity Office, 820 Chandler Street, Fort Detrick MD 21702-5014, supported by the Assistant Secretary of Defense for Health Affairs, through: a) “FY21 Spinal Cord Injury Research Program” in the amount of $490,040 under Award No. W81XWH-22-1-0605, and b) “FY24 Spinal Cord Injury Research Program Translational Research Award” in the amount of $1,315,074.00 under Award No. HT94252510369. Opinions,interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the U.S. Army or Department of Defense.
Watch the 5-minute excerpt from the talk
Video highlights and other talks by this speaker appear here.




